Spyre Therapeutics, Inc. (NASDAQ: SYRE ) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...
Bowling Green WBKO on MSN56m
TVA Partnership awards $1.5 Million in STEM Grants to 342 SchoolsThe competitive STEM classroom grant program is operated in partnership with the Tennessee STEM Innovation Network, managed ...
Wedbush raised the firm’s price target on Apogee Therapeutics (APGE) to $90 from $87 and keeps an Outperform rating on the shares. The firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback